4//SEC Filing
SCHIERMEIER ANDREW 4
Accession 0001209191-19-018817
CIK 0001652130other
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 4:38 PM ET
Size
6.9 KB
Accession
0001209191-19-018817
Insider Transaction Report
Form 4
SCHIERMEIER ANDREW
EVP, Dev and Corp Strategy
Transactions
- Purchase
Common Stock
2019-03-06$16.00/sh+3,250$52,000→ 3,250 total - Purchase
Common Stock
2019-03-06$15.50/sh+4,250$65,875→ 7,500 total
Holdings
- 8,644
Common Stock
Footnotes (1)
- [F1]Includes 1,091 and 53 shares acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on June 30, 2018 and December 31, 2018, respectively.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeother
Related Parties
1- filerCIK 0001738456
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 8:00 PM ET
- Accepted
- Mar 12, 4:38 PM ET
- Size
- 6.9 KB